Free shipping on all orders over $ 500

BMS-5

Cat. No. M6145

All AbMole products are for research use only, cannot be used for human consumption.

BMS-5 Structure
Synonym:

LIMKI 3

Size Price Availability Quantity
10mM*1mL in DMSO USD 82 In stock
1mg USD 36 In stock
5mg USD 79 In stock
10mg USD 124 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BMS-5 (LIMKi 3) is a potent LIM kinase inhibitor (IC50 values are 7 and 8 nM for LIMK1 and LIMK2 respectively). BMS-5 inhibits cofilin phosphorylation in MDA-MB-231 breast cancer cells. BMS-5 reduces MDA-MB-231 tumor cell invasion in a 3D matrigel invasion assay. COCs exhibited different diffusion situation between control and treatment group: the diffusion of 200 µM BMS-5 (LIMKi 3) treated-COCs was significantly weaker than the control group. In the standard of COCs surrounded by the cumulus cell layers, we counted the proportion of diffusion and found that the rate of good diffusion was decreased significantly (40.05 ± 3.03% vs. 20.50 ± 4.05%; p < 0.05). Oocytes were then obtained from COCs after hyaluronidase treatment, we found that few oocytes extruded the polar body after 200 µM BMS-5 (LIMKi 3) treatment.

Protocol (for reference only)
Cell Experiment
Cell lines COCs
Preparation method For LIMK1/2 inhibitor treatment, stock LIMKi 3 (50 mM in dimethylsulfoxide (DMSO)) was diluted in M199 to final concentrations of 50, 100, 150 and 200 µM. A control group was cultured in DMSO at the same relative concentration of solvent. COCs were cultured with LIMKi 3 to evaluate its effects on oocyte maturation. COCs were denuded of their cumulus cells by gentle pipetting with 0.1% (w/v) hyaluronidase.
Concentrations 200 µM
Incubation time 44 h
Animal Experiment
Animal models NF1+/− mice
Formulation DMEM × 1 containing 5% FCS
Dosages 0, 25 or 50 μM
Administration i.v.
Chemical Information
Molecular Weight 431.29
Formula C17H14Cl2F2N4OS
CAS Number 1338247-35-0
Solubility (25°C) DMSO ≥ 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jia RX, et al. PeerJ. LIMK1/2 inhibitor LIMKi 3 suppresses porcine oocyte maturation.

[2] Mashiach-Farkash E, et al. Oncotarget. Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton.

Related LIM Kinase Products
BMS-3

BMS-3 is a potent inhibitor of LIMK1.LIM kinase 1 (LIMK1) activity is essential for cell migration and cell cycle progression.

TH-257

TH-257 is a potent and selective allosteric LIMK 1/2 inhibitor with IC50 values of 84 nM and 39 nM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: BMS-5, LIMKI 3 supplier, LIM Kinase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.